معرفی
Sangeeta Tiwari is an Assistant Professor in the Biological Sciences department at the University of Texas at El Paso (UTEP), affiliated with the Border Biomedical Research Center (BBRC). Her research focuses on tuberculosis (TB) chemotherapy, bacterial pathogenesis, and host-pathogen interactions. She holds a patent for a collaborative invention, "Double Auxotrophic Mycobacterium and Uses Thereof," and received the University of Texas System’s Faculty STARs Program Award. Dr. Tiwari’s lab investigates novel mycobacterial virulence factors, vaccine development, and metabolic pathways enabling mycobacterial survival in hosts.
Education and career highlights include research at Yale School of Medicine and Albert Einstein College of Medicine, with publications in prestigious journals like PNAS, Immunity, Science, and Nature Immunology. She leads a multidisciplinary approach combining molecular biology, biochemistry, genetics, metabolomics, and immunology to address TB challenges. At UTEP, she collaborates on HIV-TB co-infection mechanisms and cancer immunotherapy.
Research interests span TB drug design, vaccines, and host-pathogen mechanisms. Her lab explores HIV-TB interactions and applies innovative methods to improve BCG vaccine efficacy. She has secured a $1.5M NIH grant for TB research. Awards include recognition from Yale and Albert Einstein institutions, alongside the Texas System STARs honor.
Key grants include NIH funding, and her work aligns with UTEP’s interdisciplinary research initiatives. She actively engages in entrepreneurship and community health projects, including UTEP’s Community Engagement and Research in COVID-19 network.
